Brad Wyman’s seen a few things over his 30-year career: the potential of medical imaging, the limits of biomarker development, and the struggles and successes inherent to translational medicine. Join host Colin Miller as Brad shares stories from the front lines of clinical development. 

• Why successful biomarkers don’t guarantee clinical success
• Engineers vs. scientists, and how Brad distinguishes between them 
• Integrated approaches to marketing and business strategy
• The impact of AI, and where Brad would invest a hypothetical $100M (hint: it’s not AI)